Keyword [Uterine leiomyosarcoma] Result: 1 - 19 | Page: 1 of 1 |
1. | Analyse Of 34 Cases Uterine Leiomyosarcoma |
2. | Expression Of P16~(INK4A), CDK4 And Cyclin D1 Protein In Uterine Smooth Muscle Tumors |
3. | Clinical Analysis Of Cellular Leiomyoma And Uterine Leiomyosarcoma |
4. | Microrna29 Leiomyosarcoma In The Expression And Its Clinical Significance |
5. | Expression Study Of P16,Bcl-2,P53,Ki-67,ER And PR Antibodies In Uterine Leiomyoma And Leiomyosarcoma |
6. | Expression And Clinical Significance Of PDGFα In The Tissue Of Uterine Leiomyosarcoma |
7. | The Isolation And Preliminary Identification Of Uterine Leiomyosarcoma Cancer Stem Cell Like Cells |
8. | A Meta-analysis Of Expressions Of Bcl-2, Ki-67, P16, P53Arid ER In Uterine Leiomyosarcoma And Their Clinical Applications |
9. | Retrospective Analysis Of 29 Uterine Leiomyosarcoma Cases And The Mutation Of P53 And MED12 |
10. | Analyze The Clinical Characteristics And Prognosis Factors For Patients With Uterine Smooth Muscle Tumors, Uterine Atypical Leiomyoma And Uterine Leiomyosarcoma |
11. | Clinical Study Of Smooth Muscle Tum-Ours Of Uncertain Malignant Potential |
12. | Clinical Analysis And The Role Of Lymphadenectomy For The Prognosis Of Uterine Sarcomas-105 Cases Report |
13. | A Study On The Expression Of CKS2 In Uterine Leiomyosarcoma And Its Influence On Tumor Biological Behaviors |
14. | Clinical,pathological And Molecular Biomarkers Analysis Of Uterine Leiomyosarcoma |
15. | The Mechanisms Of MELK Involved In The Development And Chemoresistance In Uterine Leiomyosarcoma |
16. | Clinical Analysis Of Uterine Smooth Muscle Tumors,Cellular Leiomyomaand Uterine Leiomyosarcoma |
17. | The Expression And Clinical Significance Of SUMO-1 And P53 Protein In Uterine Leiomyosarcoma |
18. | Clinical Characteristics And Postoperative Recurrence Of Cellular Uterine Leiomyoma |
19. | The Relate Risk Factors Of Uterine Leiomyosarcoma:A Meta-analysis |
|